Australia · Delayed Price · Currency is AUD Cobram Estate Olives Earnings Call Transcripts
Fiscal Year 2026
-
Underlying EBITDA was AUD 9.5 million, ahead of guidance but down year-over-year, with a net loss after tax of AUD 11.9 million due to transaction costs. The COR acquisition will expand U.S. operations and is expected to deliver significant synergies and growth.
Fiscal Year 2025
-
Record financial results were achieved, with strong growth in both Australia and the U.S., and a major capital raise is accelerating U.S. expansion. The board emphasized sustainability, risk management, and long-term value creation, while all resolutions and director re-elections were supported.
-
Record profit and cash flow were achieved, driven by strong branded sales growth in both Australia and the U.S.A. Major CapEx in Australia is complete, with future investment focused on U.S. expansion. Water costs and global supply constraints remain key risks.
-
Sales rose 13.5% to AUD 123.5 million, with EBITDA up 75% and strong growth in both Australia and the U.S. CapEx focused on U.S. expansion, and a larger Australian crop is expected to boost second-half results. Demand remains robust despite global price shifts.
Fiscal Year 2024
-
The AGM highlighted strong financial results, major growth in both Australia and the U.S.A., and a focus on sustainability and risk management. Shareholders approved all resolutions, including director elections and a fully franked dividend, while management outlined ongoing strategic investments and operational resilience.
-
Sales grew 34.6% year-over-year, with EBITDA up 63.4% and record operating cash flow. Strong growth in both Australia and the USA, with further expansion and higher EBITDA expected in FY 2025. Market share gains, robust demand, and strategic investments position the business for continued growth.